Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma
Details
Publication Year 2022-12,Volume 63,Issue #13,Page 3217-3221
Journal Title
Leukemia & Lymphoma
Publication Type
Case report
Keywords
Humans; *Panniculitis/diagnosis/etiology/therapy; *Lymphoma, T-Cell/diagnosis/therapy/pathology; *Hematopoietic Stem Cell Transplantation; *Skin Neoplasms/pathology; *Lymphoma, T-Cell, Cutaneous
Department(s)
Haematology; Pathology
PubMed ID
36070587
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-05-09 06:08:21
Last Modified: 2025-05-09 06:09:24

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙